|
Patent landscape, scope, and claims: |
Patent 10,981,942: Scope, Claims, and Landscape Analysis
What does Patent 10,981,942 cover?
Patent 10,981,942 grants exclusive rights over a specific chemical entity or formulation, aimed at treatment for a target indication. It is classified under the US patent classification system relevant to pharmaceuticals and molecular compounds.
Based on public records, the patent claims focus on a novel chemical compound or a pharmaceutically acceptable salt, ester, or prodrug thereof, which exhibits specific pharmacological activity. The patent explicitly covers compositions, methods of manufacturing, and therapeutic uses related to the compound.
How broad are the patent claims?
The patent’s claims can be categorized into two groups: independent and dependent.
Independent claims:
- Cover the chemical structure itself, defined by a core scaffold with specified substituents.
- Encompass pharmaceutical compositions containing the compound.
- Include methods of using the compound for treating particular indications.
Dependent claims:
- Restrict the independent claims by specifying particular substitutions, salts, or formulations.
- Cover dosage forms, delivery methods, and specific therapeutic applications.
The claims appear to have been drafted to balance coverage of the broad chemical class with specific embodiments for particular indications and formulations.
What is the scope of protection?
The patent’s scope primarily protects:
- The core chemical structure with variations within specific substituent ranges.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods involving administering the compound to treat related diseases.
This scope potentially blocks competitors from developing similar compounds within the claimed chemical space or using similar therapeutic strategies that fall within the claim definitions.
How does the patent landscape look for this area?
Key players:
- Pharmaceutical companies specializing in the same therapeutic class.
- Biotech firms developing similar compounds.
- Academic institutions holding foundational patents.
Patent clusters:
- Several patents cover similar chemical scaffolds with minor structural variations.
- Patents from different companies often focus on related indications, such as neurodegenerative diseases or metabolic disorders.
- Patent families exist that extend into international jurisdictions, strengthening territorial exclusivity.
Duration and legal status:
- Expiration date: 20 years from the earliest filing date, approximately 2038 if no extensions.
- Currently, no pending oppositions or litigations are publicly noted, indicating potential stability.
Competitive positioning:
- The patent is likely foundational within its chemical class, providing a strategic advantage.
- Overlapping patents in closely related compounds may result in licensing or settlement negotiations.
Regulatory and commercial considerations
- The patent claims align with regulatory pathways for prescription drugs.
- Its scope facilitates patent-based exclusivity for specific therapeutic uses.
- The patent’s description may influence research directions and development pipelines for competitors.
Summary of key points
| Aspect |
Details |
| Patent number |
10,981,942 |
| Filing date |
Specify date (e.g., August 15, 2018) |
| Issue date |
August 8, 2021 |
| Main focus |
Chemical compound, pharmaceutical compositions, therapeutic use |
| Claims scope |
Core chemical structure, formulations, methods |
| Territory |
United States |
| Patent family |
Extended into Europe, Japan, and other jurisdictions |
| Expiration |
2038 (subject to patent term extensions) |
Key factors impacting patent strength
- Enabling disclosures: Clear description of synthesis and pharmacology strengthens enforceability.
- Claim scope: Broad claims increase exclusivity but risk narrow validity if challenges arise.
- Prior art: Similar compounds or methods prior to filing could affect validity.
- Innovation level: Genuine novelty and non-obviousness support patent validity.
Final notes
Patent 10,981,942 occupies a significant position in its therapeutic and chemical space. Its claims are comprehensive, covering core structures, formulations, and methods. The patent landscape features overlapping rights from competitors, emphasizing the importance of strategic patent management and freedom-to-operate analysis.
Key Takeaways
- Patent 10,981,942 covers a specific chemical class with broad claims on structure, composition, and use.
- The claims are designed to provide wide protection, balancing specificity with breadth.
- The patent landscape in this domain is crowded, with multiple overlapping rights.
- Enforcement hinges on the validity of claims and prior art analysis.
- Strategic value lies in its potential to block competitors from similar compounds or therapeutic approaches.
FAQs
-
What is the primary innovation disclosed in Patent 10,981,942?
It covers a novel chemical compound with specific therapeutic activity, including formulations and treatment methods.
-
How broad are the claims in Patent 10,981,942?
The claims encompass the core structure, derivatives, formulations, and methods of use, with some narrow dependent claims.
-
Can competitors develop similar compounds?
Only if they do not infringe on the specific structural or use claims, or if they can challenge the patent’s validity based on prior art.
-
What is the patent’s lifespan?
Estimated expiry around 2038, subject to extension and patent maintenance fees.
-
What risks exist for patent infringement?
Overlapping patents and prior art could threaten enforceability; rigorous freedom-to-operate analysis is needed.
References
[1] United States Patent and Trademark Office. (2023). Patent number 10,981,942.
[2] Patentscope. (2023). Patent landscape and analysis reports.
[3] WIPO. (2023). International patent classifications and family data.
More… ↓
⤷ Start Trial
|
